Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Front Pharmacol ; 13: 903235, 2022.
Article in English | MEDLINE | ID: mdl-35571135

ABSTRACT

The tuber of Coeloglossum viride var. bracteatum is a Tibetan medicine that has been used for generations as a tonic for Yang and Qi, tranquilizing, to enhance intelligence and to promote longevity. We have previously characterized the constituents of Coeloglossum viride var. bracteatum extract (CE) and investigated its anti-Alzheimer's disease (AD) effect in mice models. However, the exact role of CE in Parkinson's disease (PD), especially the neurotrophic and inflammatory pathways regulated by CE, remains unknown. In this study, we investigated the anti-PD effects of CE in an MPTP-induced acute mouse model and its underlying mechanisms, focusing on BDNF, FGF2 and their mediated signaling pathways and RIP1-driven inflammatory signaling axis. Pole test and traction test were performed for behavioral analysis. RT-PCR, IHC and Western blotting were performed to assay the mRNA, tissues, and protein, respectively. We found that CE improved dyskinesia in MPTP-intoxicated mice, which was confirmed by the pole test and traction test. Also, oxidative stress and astrocyte activation and inflammation were alleviated. MPTP-intoxication disrupted the levels of BDNF, FGF2 and their mediated signaling pathways, triggered elevation of pro-inflammatory factors such as TNF-α, IL-1ß, and IL-6, and activated RIP1-driven inflammatory axis. However, CE restored the levels of BDNF, FGF2 and TrkB/Akt signaling pathways while inhibiting the RIP1-driven inflammatory signaling axis, thereby inhibiting apoptosis, preventing loss of nigrostriatal neurons, and maintaining cellular homeostasis. Thus, CE is a promising agent for the treatment of PD.

2.
J Ethnopharmacol ; 285: 114834, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-34801609

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Semen Cuscutae, called Tu-si-zi in Chinese, is a kind of dried mature seed in the Convolvulaceae family. It mainly distributes in China, Korea, Pakistan, Vietnam, India and Thailand. It is used as a kidney-tonifying drug for treatment of aging related diseases such as osteoporosis in traditional Chinese medicine. However, the exact mechanisms on bone resorption are poorly studied. AIM OF THE STUDY: The aim of this study was to investigate the potential effect of Semen Cuscutae on ovariectomy (OVX)-induced osteoporosis in mice and clarify the exact mechanisms by which Semen Cuscutae exert the anti-osteoporosis effect. MATERIALS AND METHODS: Qualitative and quantitative analyses of Semen Cuscutae were performed by UPLC-Q-TOF-MS and HPLC-MS/MS, respectively. Changes in bone mineral density (BMD) induced by OVX in mice were measured by dual-energy X-ray absorptiometry and micro-computed tomography (µCT). Tartrate-resistant acid phosphatase (TRAP) staining as well as hematoxylin and eosin (HE) staining were used to observe bone microarchitectural changes. ELISA kits were used to assess the therapeutic effects of Semen Cuscutae on the serum levels of osteoprotegerin (OPG), tartrate-resistant acid phosphatase 5b (TRACP-5b), and receptor activator of nuclear factor-κB (RANKL). The effect of Semen Cuscutae on primary cell viability was assessed using CCK-8 and anti-tartrate phosphatase assays. TRAP staining and actin ring staining were used to observe the effect of Semen Cuscutae on osteoclast differentiation. Western blotting was used to measure the effects of Semen Cuscutae on expressions of NFATC1, c-Src kinase, and c-fos. RESULTS: Results from UPLC-Q-TOF-MS showed that the main components of Semen Cuscutae were flavonoid compounds that included quercitrin, quercetin, hyperoside, caffeic acid, rutin, chlorogenic acid, luteolin, apigenin, kaempferol, isoquercetin, cryptochlorogenic acid, isorhamnetin-3-O-glucoside, and astragalin. After the Semen Cuscutae extract was orally administered to OVX mice, bone density increased (P < 0.01) and bone microstructure was significantly improved (P < 0.01 or 0.05). Additionally, Semen Cuscutae exhibited a significant descending effect in the levels of serum TRACP-5b and RANKL, while there was a significant increase in OPG in the Semen Cuscutae group compared with the OVX group, especially at high doses. Moreover, we found that increasing of c-fos, c-Src kinase, and NFATC1 protein expressions were reversed by Semen Cuscutae in vitro and in vivo. CONCLUSIONS: Our results showed that Semen Cuscutae exhibited anti-osteoporosis effects through the c-fos/c-Src kinase/NFATC1 signaling pathway.


Subject(s)
Bone Resorption , Drugs, Chinese Herbal/pharmacology , Osteoporosis , Signal Transduction/drug effects , Absorptiometry, Photon/methods , Animals , Bone Density Conservation Agents/pharmacology , Bone Resorption/diagnostic imaging , Bone Resorption/drug therapy , Bone Resorption/metabolism , CSK Tyrosine-Protein Kinase/metabolism , Mice , NFATC Transcription Factors/metabolism , Osteoclasts/drug effects , Osteoclasts/physiology , Osteoporosis/drug therapy , Osteoporosis/metabolism , Plant Extracts/pharmacology , Proto-Oncogene Proteins c-fos/metabolism , X-Ray Microtomography/methods
3.
J Ethnopharmacol ; 282: 114606, 2022 Jan 10.
Article in English | MEDLINE | ID: mdl-34506939

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Tibetan ginseng named Wangla (tuber of Coeloglossum viride var. bracteatum) is a traditional tonic that has Yang-strengthening and qi-enhancing, tranquilizing, intelligence-enhancing and longevity-enhancing properties. It has been used to treat impotence, spermatorrhea, anemia and insomnia. Therefore, its characteristic components and neuronal modulating effects were studied. AIM OF THE STUDY: To investigate the elimination of Aß-induced toxicity by CE and to elucidate the molecular mechanisms involving BDNF, FGF2, and their related signaling axis, and the RIP1-driven inflammatory pathway. MATERIALS AND METHODS: We established Aß-induced toxicity models in cultured neurons and ICR mice, respectively. MWM and fear conditioning tests were performed for behavioral analysis of cognitive functions in mice. Western blot was used to investigate the levels of BDNF, FGF2, and their downstream effector TrkB/Akt/Bcl-2, as well as the RIP1-driven RIP1/RIP3/MLKL pathway. Immunofluorescence assay is used to examine the status of glial cells. RESULTS: CE abrogated Aß toxicity and inhibited apoptosis in cultured neurons, mainly by regulating the BDNF, FGF2, and TrkB/Akt signaling pathways as well as RIP1-driven inflammation and necroptosis. Similarly, mice injected intracerebrally with Aß exhibited cognitive deficits and had elevated oxidative stress and inflammatory factors detected in their serum and brain. However, CE-treated mice showed recovery of cognitive abilities and quelled levels of oxidative stress and inflammatory factors. Moreover, Aß toxicity led to a reduction in BDNF, FGF2, and related signaling regulators in the hippocampus and prefrontal cortex, accompanied by activation of RIP1-driven inflammatory signaling pathways, and a reduction in TBK1 and Bcl-2. However, CE restored the levels of BDNF, FGF2, and TrkB/Akt signaling pathway, while inhibiting RIP1-induced RIP1/RIP3/MLKL pathway, thereby antagonizing apoptosis and maintaining neuronal activity. CONCLUSIONS: CE effectively eliminated the toxicity of Aß in cultured neurons and mouse models, which holds promise for drug development.


Subject(s)
GTPase-Activating Proteins/metabolism , Necroptosis/drug effects , Orchidaceae , Protein Kinases/metabolism , Receptor-Interacting Protein Serine-Threonine Kinases/metabolism , Signal Transduction/drug effects , Animals , Anti-Inflammatory Agents/pharmacology , Behavior, Animal/drug effects , Brain-Derived Neurotrophic Factor/metabolism , Disease Models, Animal , Fibroblast Growth Factor 2/metabolism , Mice , Mice, Inbred ICR , Neurons/drug effects , Neurons/metabolism , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Plant Extracts/pharmacology
4.
Inflamm Res ; 70(10-12): 1151-1164, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34661679

ABSTRACT

OBJECTIVE: Gisenoside Rg1 is a potent neuroprotectant in ginseng. The aim of this study was to investigate the elimination effect of Rg1 on cadmium (Cd)-induced neurotoxicity. MATERIALS AND METHODS: A cumulative Cd exposure mouse model was established. Also, the toxicity of Cd and the protective effect of Rg1 were examined in vitro using cultured neurons and microglia. RESULTS: We found that Cd-intoxicated mice exhibited significant injury in the liver, kidney, small intestine, and testis, along with cognitive impairment. Antioxidant enzymes such as SOD, GSH-Px and CAT were reduced in the blood and brain, and correspondingly, the lipid peroxidation product MDA was elevated. In the brain, astrocytes and microglia were activated, characterized by an increase in inflammatory factors such as TNF-α, IL-1ß and IL-6, as well as their protein markers GFAP and IBA1. However, Rg1 eliminated Cd-induced toxicity and restored oxidative stress and inflammatory responses, correspondingly restoring the behavioral performance of the animals. Meanwhile, the BDNF-TrkB/Akt and Notch/HES-1 signaling axes were involved in the Rg1-mediated elimination of Cd-induced toxicity. CONCLUSION: Rg1 is a promising agent for the elimination of Cd-induced toxicity.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Cadmium , Ginsenosides/therapeutic use , Neuroprotective Agents/therapeutic use , Neurotoxicity Syndromes/drug therapy , Animals , Anti-Inflammatory Agents/pharmacology , Apoptosis/drug effects , Brain/drug effects , Brain/immunology , Brain/pathology , Cell Survival/drug effects , Cells, Cultured , Cytokines/genetics , Cytokines/immunology , Ginsenosides/pharmacology , Intestine, Small/drug effects , Intestine, Small/pathology , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Male , Mice, Inbred C57BL , Microglia/drug effects , Microglia/pathology , Neurons/drug effects , Neurons/pathology , Neuroprotective Agents/pharmacology , Neurotoxicity Syndromes/immunology , Neurotoxicity Syndromes/pathology , Oxidative Stress/drug effects , Oxidoreductases/immunology , Testis/drug effects , Testis/pathology
5.
J Ethnopharmacol ; 270: 113815, 2021 Apr 24.
Article in English | MEDLINE | ID: mdl-33444724

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Erzhi formula (EZF) consists of Ecliptae herba (EH) and Fructus Ligustri Lucidi (FLL) at a ratio 1:1, and constitutes a well-known formula in China that is commonly used for treating menopausal diseases. AIM OF THE STUDY: In this study, we explored the pharmacologic actions and potential molecular mechanisms underlying EZF's action in preventing and treating osteoporosis. MATERIALS AND METHODS: The active components and related targets of EZF's anti-osteoporotic effects were predicted by network pharmacology, and functional enrichment analysis was also performed. We then used an osteoporosis model of ovariectomized (OVX) mice to detect the effects of EZF on osteoporosis. RESULTS: The results from network pharmacology identified a total of 10 active ingredients from EH and 13 active ingredients from FLL that might affect 65 potential therapeutic targets. GO enrichment analysis revealed that EZF affected bone tissue primarily via hormone (particularly estradiol)-related pathways and bone resorption by osteoclast differentiation. KEGG analysis demonstrated that bone-related factors such as Runt-related transcription factor 2 (Runx2), Ca2, estrogen receptor1 (ESR1), androgen receptors (AR), and TNFα served as the primary targets during osteoclastic differentiation. In vivo experiments showed that the formula significantly improved the diminution in estrogen and the subsequent uterine atrophy induced by ovariectomy (P < 0.01 or 0.05), implying that the EZF exerted its actions via regulation of estradiol and the nourishing effects of the uterus in OVX mice. Dual-energy X-ray absorptiometry and micro-CT showed that EZF significantly inhibited bone loss and improved bone micro-architecture by statistically increasing the number of bone trabeculae and decreasing the separation of bone trabeculae in OVX mice (P < 0.01 or 0.05); EZF also inhibited bone loss and enhanced bone-fracture load. Furthermore, we confirmed that EZF reduced the calcium concentrations, augmented protein and mRNA levels for Runx2 in the bone marrow, and reduced PPARγ levels. RANKL-a key downstream regulatory protein of many targets that was referred to in our results of network pharmacology as being involved in the regulation of osteoclastogenesis-was significantly diminished by EZF; it also elevated OPG content. In addition, we used monocytes of bone-marrow origin to detect the effects of the potential components of EZF on osteoclast differentiation and found that wedelolactone, oleanolic acid, echinocystic acid, luteolin, and luteolin-7-o-glucoside significantly inhibited osteoclast differentiation from monocytes induced by 25 ng/mL MCSF and 50 ng/mL RANKL (P < 0.01 or 0.05). CONCLUSIONS: Our present study indicated that EZF significantly inhibited the bone loss induced by OVX in mice by its regulation of estradiol combined with the nourishing effect of the uterus, and that it also attenuated bone resorption by decreasing the RANKL/OPG ratio so as to inhibit osteoclast maturation.


Subject(s)
Bone Resorption/prevention & control , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Osteoclasts/drug effects , Osteoporosis, Postmenopausal/prevention & control , Animals , Bone Resorption/metabolism , Bone and Bones/drug effects , Bone and Bones/metabolism , Bone and Bones/pathology , Cell Differentiation/drug effects , Disease Models, Animal , Drugs, Chinese Herbal/chemistry , Eclipta/chemistry , Estradiol/metabolism , Female , Humans , Kruppel-Like Factor 4 , Ligustrum/chemistry , Metabolic Networks and Pathways/drug effects , Mice, Inbred C57BL , Osteoclasts/cytology , Osteogenesis/drug effects , Osteoporosis, Postmenopausal/etiology , Osteoporosis, Postmenopausal/metabolism , Ovariectomy/adverse effects , RANK Ligand/metabolism , Uterus/drug effects
6.
Int J Med Sci ; 17(8): 1048-1055, 2020.
Article in English | MEDLINE | ID: mdl-32410834

ABSTRACT

Ginsenoside Rg1 is the main active ingredient of Panax ginseng with the activity of neuroprotective, antioxidant and strengthening the immune system. Therefore, we hypothesized that Rg1 may afford anti-aging effects although the mechanism remains to be elucidated. In this study, chemically induced aging mice were established by consecutive administration of D-galactose and AlCl3. We found that Rg1 effectively ameliorates spatial learning and memory deficits in aging mice demonstrated by their improved performance in step down avoidance tests and Morris water maze experiments. Rg1 restored aging-induced decline of FGF2 and BDNF, reactivated TrkB/Akt signaling pathways in the hippocampus and prefrontal cortex to inhibit apoptosis, for the expression of anti-apoptotic protein Bcl-2 and apoptosis promoting enzyme cleaved-Caspase3 were antagonistically restored. Therefore, these results established the anti-aging effects of Rg1, and FGF2, BDNF and associated signaling pathways might be promising targets. Our data may provide a new avenue to the pharmacological research and diet therapeutic role of ethnic products such as Rg1 in anti-aging and aging associated diseases.


Subject(s)
Antioxidants/pharmacology , Cognitive Dysfunction/drug therapy , Ginsenosides/pharmacology , Signal Transduction/drug effects , Aging/drug effects , Aging/physiology , Aluminum Chloride/administration & dosage , Aluminum Chloride/toxicity , Animals , Antioxidants/therapeutic use , Apoptosis/drug effects , Behavior Observation Techniques , Behavior, Animal/drug effects , Brain-Derived Neurotrophic Factor/metabolism , Cognition/drug effects , Cognitive Dysfunction/chemically induced , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/physiopathology , Disease Models, Animal , Fibroblast Growth Factor 2/metabolism , Galactose/administration & dosage , Galactose/toxicity , Ginsenosides/therapeutic use , Hippocampus/drug effects , Hippocampus/pathology , Humans , Male , Membrane Glycoproteins/metabolism , Mice , Panax/chemistry , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/physiology
7.
Neuroscience ; 430: 25-33, 2020 03 15.
Article in English | MEDLINE | ID: mdl-32007553

ABSTRACT

Depression is a long term inhibitory mood that heavily disabled human beings. We have previously demonstrated anti-depression effect of 2,3,5,4'-tetrahydroxystilbene-2-O-ß-d-glucoside (THSG) in chronic-restraint stress (CRS) induced depressive-like mice by restoring the oxidative pathway and neuroinflammation. In this study, we examine the conditions of neurotrophins in CRS-induced depressive-like mice and whether THSG could be an antidepressant by ameliorating the neurotrophins and their associated signaling axis. CRS produced downregulation of antioxidants, the decline of brain-derived neurotrophic factor (BDNF), fibroblast growth factor 2 (FGF2) and associated signaling regulators in the hippocampus and prefrontal cortex, corresponding to the behavioral inability and anhedonia. Administration of THSG restored the expression of antioxidants and neurotrophins BDNF, FGF2. Besides, THSG recovered the Akt signaling pathway and antagonistically restored the expression of Bcl-2 and cleaved-caspase-3 to inhibit apoptosis. Consistently, behavioral performances were recovered from CRS-induced motor inability and anhedonia. In summary, THSG is effective to attenuate stress-induced depression by ameliorating the biochemistry of neurotrophins and their related signaling pathways. These results may provide an avenue to take BDNF as a target to explore folk medicine for anti-depression.


Subject(s)
Brain-Derived Neurotrophic Factor , Fibroblast Growth Factor 2 , Animals , Brain-Derived Neurotrophic Factor/metabolism , Depression/drug therapy , Glucosides , Hippocampus/metabolism , Mice , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , Stilbenes , Stress, Psychological/complications , Stress, Psychological/drug therapy
8.
Food Funct ; 10(9): 6009-6019, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31482900

ABSTRACT

The major bioactive ingredient THSG of Polygonum multiflorum is well established for its anti-oxidation, anti-aging and anti-inflammation properties. Increasing evidence supports the capacity of THSG to ameliorate the biochemistry of neurotrophins and their downstream signaling axis in mouse models to attenuate neurodegenerative diseases such as Alzheimer's and Parkinson's disease. In this study, the neuroprotective effects of THSG were studied in vitro and in vivo. In cultured mesencephalic dopamine neurons and SH-SY5Y cell line, it was found that THSG protected the integrity of the cell body and neurite branching from MPP+-induced toxicity by restoring the expression of FGF2 and BDNF and their downstream signaling pathways to inhibit apoptosis and promote cell survival. The inhibition of Akt signaling by LY294002 or TrkB activity by K252a eliminated the neuroprotective effects of THSG. In the MPTP-induced mouse models of Parkinson's disease, THSG ameliorated the animal behaviors against MPTP-induced neurotoxicity, which was demonstrated by the pole test and the tail suspension test. Biochemical and immunohistochemical analysis verified the THSG-mediated restoration of the FGF2-Akt and BDNF-TrkB signaling axis in the substantia nigra and corpus striatum and the recovery of dopaminergic neurons. These results establish the neuroprotective effects of THSG in vitro and in vivo and unravel the underlying mechanism against toxin-induced neural atrophy, providing a new avenue for the use and pharmacological research of edible medicine for anti-neurodegenerative diseases.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Drugs, Chinese Herbal/administration & dosage , Fibroblast Growth Factor 2/metabolism , Glucosides/administration & dosage , Membrane Glycoproteins/metabolism , Neuroprotective Agents/administration & dosage , Parkinson Disease/drug therapy , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Stilbenes/administration & dosage , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/adverse effects , 1-Methyl-4-phenylpyridinium/adverse effects , Animals , Apoptosis/drug effects , Brain-Derived Neurotrophic Factor/genetics , Cell Survival/drug effects , Dopaminergic Neurons/cytology , Dopaminergic Neurons/drug effects , Fallopia multiflora/chemistry , Fibroblast Growth Factor 2/genetics , Humans , Male , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Parkinson Disease/genetics , Parkinson Disease/metabolism , Protein-Tyrosine Kinases/genetics , Proto-Oncogene Proteins c-akt/genetics , Signal Transduction/drug effects
9.
Sci Rep ; 7(1): 9209, 2017 08 23.
Article in English | MEDLINE | ID: mdl-28835690

ABSTRACT

The excessive release and accumulation of glutamate in the brain is known to be associated with excitotoxicity. CE, an extract derived from the plant Coeloglossum viride var. Bracteatum, exerted neuroprotective effects against amyloid toxicity and oxidative stress in cortical neurons. The aims of this study are to examine whether CE also attenuates glutamate neurotoxicity in rat primary cultured cortical neurons and to determine the effect of CE in vivo. According to the results of MTT, LDH release, and TUNEL assays, the CE treatment significantly reduced glutamate-induced neurotoxicity in a dose-dependent manner. Moreover, the protective effects of CE were blocked by an Akt inhibitor, LY294002, suggesting that the PI3K/Akt signalling pathway is involved in the neuroprotective effects of CE. In addition, CE might regulate the PKC-GluA2 axis to prevent neuronal apoptosis. CE also protected against dopaminergic neuronal loss in a mouse model of MPTP-induced PD. Based on our results, CE exerted neuroprotective effects both in vitro and in vivo, thus providing a potential therapeutic target for the treatment or prevention of neurodegeneration.


Subject(s)
Neuroprotective Agents/chemistry , Neuroprotective Agents/pharmacology , Orchidaceae/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Animals , Cerebral Cortex/cytology , Cerebral Cortex/metabolism , Disease Models, Animal , Fluorescent Antibody Technique , Glutamic Acid/metabolism , Glutamic Acid/pharmacology , Immunohistochemistry , Mice , Neurons/drug effects , Neurons/metabolism , Oxidative Stress , Parkinson Disease/drug therapy , Parkinson Disease/etiology , Parkinson Disease/metabolism , Parkinson Disease/pathology , Phosphatidylinositol 3-Kinases/metabolism , Protein Kinase C/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats
10.
Oxid Med Cell Longev ; 2016: 2050435, 2016.
Article in English | MEDLINE | ID: mdl-26788243

ABSTRACT

Green tea polyphenols are a natural product which has antioxidative and antiapoptotic effects. It has been shown that glutamate excitotoxicity induced oxidative stress is linked to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. In this study we explored the neuroprotective effect of green teen polyphenols against glutamate excitotoxicity in the primary cultured cortical neurons. We found that green tea polyphenols protected against glutamate induced neurotoxicity in the cortical neurons as measured by MTT and TUNEL assays. Green tea polyphenols were then showed to inhibit the glutamate induced ROS release and SOD activity reduction in the neurons. Furthermore, our results demonstrated that green tea polyphenols restored the dysfunction of mitochondrial pro- or antiapoptotic proteins Bax, Bcl-2, and caspase-3 caused by glutamate. Interestingly, the neuroprotective effect of green tea polyphenols was abrogated when the neurons were incubated with siBcl-2. Taken together, these results demonstrated that green tea polyphenols protected against glutamate excitotoxicity through antioxidative and antiapoptotic pathways.


Subject(s)
Antioxidants/pharmacology , Apoptosis/drug effects , Cerebral Cortex/pathology , Glutamic Acid/toxicity , Neurons/pathology , Neurotoxins/toxicity , Polyphenols/pharmacology , Tea/chemistry , Animals , Caspase 3/metabolism , Cells, Cultured , Neurons/drug effects , Neurons/metabolism , Neuroprotection/drug effects , Oxidative Stress/drug effects , bcl-2-Associated X Protein/metabolism
11.
Zhen Ci Yan Jiu ; 39(4): 278-81, 317, 2014 Aug.
Article in Chinese | MEDLINE | ID: mdl-25219122

ABSTRACT

OBJECTIVE: To observe the effect of acupuncture stimulation of "Dazhui" (GV 14), bilateral "Fengmen" (BL 12) and "Feishu" (BL 13) on the thickness of the bronchial tubal wall and smooth muscle and expression of transforming growth factor-beta1 (TGF-beta1) in asthma rats so as to reveal its mechanism underlying improvement of asthma. METHODS: Forty SD rats were randomly assigned to control, model, acupuncture and medication groups. The asthma model was induced by subcutaneous injection of 1% egg albumin solution and forced inhalation of atomized ovalbumin. Rats of the acupuncture group were treated by acupuncture stimulation of GV 14, bilateral BL 12 and BL 13 (once daily for 10 days), and rats of the medication group treated by intraperitoneal injection of Aminophylline Injection (100 mg/kg, once daily for 10 days). The thickness of the bronchial tubal wall and airway smooth muscle of the lung tissue were measured by image analyzer for assessing the degree of airway remodeling. The expression of TGF-beta1 in the small airway was detected by immunohistochemistry. RESULTS: Compared to the control group, the thickness of the airway wall and smooth muscle, and the expression level of TGF-beta1 were remarkably increased in the model group (P < 0.01). After acupuncture intervention and medication treatment, the thickness of the airway wall and smooth muscle, and the expression level of TGF-beta1 were remarkably down-regulated in both groups in comparison with those of the model group (P < 0.05, P < 0.01), and the expression of TGF-beta1 in the acupuncture group was obviously lower than that of the medication group (P < 0.05). CONCLUSION: Acupuncture stimulation of GV 14, bilateral BL 12 and BL 13 can down-regulate bronchial asthma-induced increase of TGF-[, expression in the lung tissue in asthma rats, which may contribute to its effect in improving airway remodeling.


Subject(s)
Acupuncture Therapy , Airway Remodeling , Asthma/therapy , Transforming Growth Factor beta1/genetics , Animals , Asthma/genetics , Asthma/metabolism , Asthma/parasitology , Bronchi/metabolism , Female , Humans , Male , Muscle, Smooth/metabolism , Rats , Rats, Sprague-Dawley , Transforming Growth Factor beta1/metabolism
12.
Neurosci Bull ; 28(5): 606-10, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23054638

ABSTRACT

OBJECTIVE: Curcumin is extracted from the turmeric plant (Curcuma longa Linn.) and is widely used as a food additive and traditional medicine. The present study investigated the activity of curcumin against staurosporine (STS) toxicity in cell culture. METHODS: Rat hippocampal neurons in primary culture were exposed to STS (20 µmol/L) and treated with curcumin (20 µmol/L). Cell viability was tested by MTT assay and reactive oxygen species (ROS) were measured using the MitoSOX™ red mitochondrial superoxide indicator. Western blot was used to assess changes in the levels of caspase-3 (Csp3), heat shock protein 70 (Hsp70) and Akt. RESULTS: The results showed that curcumin protects against STS-induced cytotoxicity in rat hippocampal neurons. Csp3, Hsp70, Akt and ROS activation may be involved in this protection. CONCLUSION: Curcumin could be a potential drug for combination with STS in cancer treatment to reduce the unwanted cytotoxicity of STS.


Subject(s)
Curcumin/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Staurosporine/antagonists & inhibitors , Staurosporine/toxicity , Animals , Animals, Newborn , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Hippocampus/drug effects , Hippocampus/metabolism , Neurons/metabolism , Rats , Rats, Sprague-Dawley
13.
Neurosci Lett ; 513(2): 170-3, 2012 Apr 04.
Article in English | MEDLINE | ID: mdl-22381400

ABSTRACT

The present study was performed to explore the effect of green tea polyphenols on the intracellular Aß (iAß)-induced toxicity to cultured rat primary prefrontal cortical neurons. Administration of 100nM, 1µM or 10µM of green tea polyphenols significantly inhibited the iAß-induced toxicity to cultured rat primary prefrontal cortical neurons tested by MTT and LDH release assays. We further studied the involvement of neuroprotective pathway protein AKT in green tea polyphenols protection against iAß-induced cytotoxicity on cultured rat primary prefrontal cortical neurons. The results demonstrated that the content of p-AKT decreased significantly after iAß treatment, while administration of green tea polyphenols significantly inhibited the iAß-induced decrease in the content of p-AKT. Moreover, blockade of AKT signalling inhibited the protective effects of green tea polyphenols against iAß-induced neurotoxicity. The results suggest that green tea polyphenols may play a protective effect on cultured rat primary prefrontal cortical neurons against iAß-induced cytotoxicity and AKT is involved in the green tea polyphenols-induced protective effects.


Subject(s)
Amyloid beta-Peptides/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Polyphenols/pharmacology , Prefrontal Cortex/drug effects , Tea , Animals , Apoptosis/drug effects , Cell Survival/drug effects , Cells, Cultured , Neurons/metabolism , Neurons/pathology , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Rats , Rats, Sprague-Dawley
14.
Int J Clin Exp Med ; 3(1): 88-94, 2010 Mar 20.
Article in English | MEDLINE | ID: mdl-20369044

ABSTRACT

CE is the extract from Coeloglossum viride var.bracteatum, a plant widely used as a traditional medicine in the Southwest China, such as Tibet. The effects of CE against amyloid toxicity in cell culture were examined in the present study. The results indicate that CE can protect against amyloid beta (Abeta)(25-35)-induced cytotoxicity in rat primary prefrontal cortex neurons. Bcl(2) and Csp3 activation may be involved in CE protection. CE could be a promising candidate for amyloid-based Alzheimer's disease (AD) prevention or therapy.

15.
Immunopharmacol Immunotoxicol ; 32(1): 51-5, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19653860

ABSTRACT

BACKGROUND AND AIM: Tanshione IIA (TSN) is the major active component of Salvia miltiorrhiza, a traditional Chinese Medicine. TSN protects against antioxidant-induced liver injury, although the exact mechanism is not well understood. MATERIALS AND METHODS: In this study, the protective effects of TSN was examined by enzyme-linked immunosorbent assay (ELISA) and histochemistry of several cytokines. RESULTS: TSN is found to significantly reduce plasma alanin aminotransferase and aspartate amino transferase levels in mice with concanavalin A-induced immune-mediated liver injury. TSN increases T lymphocyte subset CD3+, CD4+ and CD8+ ratios.Also, TSN significantly reduces inflammatory cytokines, including interleukin-2, interleukin-4, interferon-gamma and tumor necrosis factor alpha, while elevates anti-inflammatory cytokine, interleukin-10. CONCLUSIONS: TSN may provide a potential drug candidate for liver injury therapeutics.


Subject(s)
Cytokines/biosynthesis , Liver/drug effects , Lymphocyte Activation/drug effects , Phenanthrenes/pharmacology , T-Lymphocyte Subsets/drug effects , Abietanes , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Concanavalin A/toxicity , Liver/pathology , Male , Mice , T-Lymphocyte Subsets/immunology
SELECTION OF CITATIONS
SEARCH DETAIL